We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Clinical Reference · Medically Reviewed
A side-by-side clinical comparison written by board-certified menopause specialists — so you know exactly where you are and what to do next.
Reviewed by Dr. Ana Lisa Carr, MD, MBA · Last reviewed 2026-05-10
In perimenopause, the goal is to smooth out hormonal volatility — symptoms come from fluctuation, not just decline. Cyclic or continuous hormone therapy may be appropriate, often at lower doses than postmenopausal regimens. Mental wellness support and sleep optimization carry outsized impact during this stage.
In menopause and postmenopause, the goal is to restore physiologic estrogen to relieve symptoms and reduce the long-term risks of hypoestrogenism (bone loss, genitourinary syndrome, cardiovascular changes). Standard regimens use transdermal estradiol with micronized progesterone for women who still have a uterus.
Specialized treatment for the transition years.
Menopause HRT →Bioidentical hormone therapy for menopause and beyond.
Take the symptom checker →2 minutes. Personalized starting point.
Perimenopause is the years of hormonal fluctuation while you still get periods (even irregular ones). Menopause is the moment you have gone 12 consecutive months without a period. The years afterward are postmenopause.
Yes. Hormone therapy is FDA-approved and evidence-supported for symptomatic perimenopausal women. Kindr providers tailor regimens differently in perimenopause vs. postmenopause because remaining cycle activity changes the dosing strategy.
Approximately 51 years in the United States. Menopause before age 40 is called premature ovarian insufficiency and warrants specialized evaluation.
No. Many women experience hot flashes during late perimenopause — sometimes years before their last period.
No. Treatment is offered when symptoms interfere with sleep, mood, work, relationships, or quality of life. Severity — not stage — drives the decision.
Medically reviewed by Dr. Ana Lisa Carr, MD, MBA
Board-Certified Family Medicine Physician · Lead Provider / Medical Reviewer
NPI 1689841744 · Last reviewed: May 10, 2026